Biofidelity developed a revolutionary molecular diagnostic assay that enables the rapid detection of target DNA sequences. Biofidelity’s mission is to improve and extend patients’ lives by enabling early detection of disease and better targeting of treatments with applications spanning oncology, prenatal testing, infectious disease, and organ transplant monitoring. Biofidelity was founded in 2019 and is headquartered of Cambridge, England.

Software Engineering

Data Science

Quality Assurance

Cambridge, UK

United Kingdom

Biofidelity

Series B

We seek talented teams intent on building businesses that can scale to create or transform an industry. If this describes you, then please get in touch

Job opportunities in the Octopus Ventures portfolio